Monrovia, CA, July 18, 2008 --(PR.com
)-- Dr. Davie’s presentation will explore strategic challenges facing sponsors and contract researchers alike, and assesses the emerging solutions including site selection, patient recruitment and retention, how the CRO models have changed over the last few years, how to ensure quality in increasingly complex and global studies, and where are the future markets for the CROs? To see a full summary of Dr. Davie’s presentation, please visit http://gtcbio.com/conferenceDetails.aspx?id=127.
GTCbio’s Global Clinical Trial Operations conference brings together leaders including directors, vice presidents, heads, managers, supervisors, from all over the world to collaborate and discuss the latest developments in clinical trial operations and logistics and covers clinical trials in emerging markets, first-in-man clinical trials, pediatric clinical trials, material storage, distribution, site selection, patient recruitment and retention, technology in clinical trials and case studies of running global clinical trials.
For more information including a detailed agenda, exhibitor opportunities and registration information visit http://gtcbio.com/conferenceDetails.aspx?id=127.
GTCbio organizes conferences specifically for the biomedical and biopharmaceutical industries. Their goal is to facilitate the exchange of biopharmaceutical and biomedical intelligence between industry leaders, academic and government organizations, and the financial community.
GTCbio is a subsidiary of Global Technology Community, LLC, a privately held company founded in 2002.
Contact: GTCBIO 434 W. Foothill Blvd. Monrovia, CA 91016 Tel: (626) 256-6405 fax: (626) 256-6460 email: email@example.com